Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K van Besien

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Thrombosis Research|April 1, 1991
Pregnancy associated with lupus anticoagulant and heparin induced thrombocytopenia: management with a low molecular weight heparinoidK van Besien, R Hoffman, A Golichowski
American Journal of Hematology|May 1, 1992
Relapsing polychondritis: a paraneoplastic syndrome associated with myelodysplastic syndromesK Van Besien, G Tricot, R Hoffman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Primary mediastinal B-cell lymphoma: a review of pathology and managementK van Besien, M Kelta, P Bahaguna
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Central nervous system relapse of lymphoid malignancies in adults: the role of high-dose chemotherapyK van Besien, A Forman, R Champlin
Cytotherapy|August 27, 2002
Autologous and allogeneic transplantation for aggressive NHLS M Smith, D Grinblatt, K van Besien
Bone Marrow Transplantation|October 19, 2004
Stem cell transplantation in follicular lymphoma: progress at last?W W Tse, H M Lazarus, K Van Besien
Leukemia|August 23, 2001
Allogeneic and autologous transplantation for chronic lymphocytic leukemiaK van Besien, B Keralavarma, S Devine, et al.
The Cancer Journal From Scientific American|February 11, 1998
Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cellsK van Besien, K Margolin, R Champlin, et al.
Bone Marrow Transplantation|November 21, 2007
Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-toleranceJ Kline, S Subbiah, H M Lazarus, et al.
Bone Marrow Transplantation|August 6, 1999
Toxicity of single daily dose gentamicin in stem cell transplantationD Warkentin, C Ippoliti, J Bruton, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Thrombosis Research|April 1, 1991
Pregnancy associated with lupus anticoagulant and heparin induced thrombocytopenia: management with a low molecular weight heparinoidK van Besien, R Hoffman, A Golichowski
American Journal of Hematology|May 1, 1992
Relapsing polychondritis: a paraneoplastic syndrome associated with myelodysplastic syndromesK Van Besien, G Tricot, R Hoffman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Primary mediastinal B-cell lymphoma: a review of pathology and managementK van Besien, M Kelta, P Bahaguna
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Central nervous system relapse of lymphoid malignancies in adults: the role of high-dose chemotherapyK van Besien, A Forman, R Champlin
Cytotherapy|August 27, 2002
Autologous and allogeneic transplantation for aggressive NHLS M Smith, D Grinblatt, K van Besien
Bone Marrow Transplantation|October 19, 2004
Stem cell transplantation in follicular lymphoma: progress at last?W W Tse, H M Lazarus, K Van Besien
Leukemia|August 23, 2001
Allogeneic and autologous transplantation for chronic lymphocytic leukemiaK van Besien, B Keralavarma, S Devine, et al.
The Cancer Journal From Scientific American|February 11, 1998
Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cellsK van Besien, K Margolin, R Champlin, et al.
Bone Marrow Transplantation|November 21, 2007
Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-toleranceJ Kline, S Subbiah, H M Lazarus, et al.
Bone Marrow Transplantation|August 6, 1999
Toxicity of single daily dose gentamicin in stem cell transplantationD Warkentin, C Ippoliti, J Bruton, et al.
Pageof 8